The only biotech and pharma newsletter you'll actually need.
TLDR Biotech
Daily coverage of the biotech and pharma industry, straight to your inbox and all in one email.
Trusted by 1900+ biotech and pharma professionals.
Don't know what this is all about? See the FAQ section below 👇👇
TESTIMONIALS
What Your Peers Are Saying
“I’ve really enjoyed [the TLDR Biotech] updates - both the information they convey and how it’s conveyed. We do a lot of work in the CGT space and I like having [these] updates as a reminder for me to keep active in reading up on information.”
Mike Keens
CEO, Sabai Global
“What I appreciate about [the TLDR Biotech] newsletter is how easy to read it is. I really like that you don't write more than necessary about any of the news but rather provide links for further info. This way I definitely read it entirely and not stop halfway through.”
Urska Rauter Gaber
CEO, Meetings.bio
“I like the comprehensive and digestible style. Not just the good stuff, but the bad and the ugly too. And in a quick-to-read format. Nice to have in my inbox!”
Jeff Bissen
Director of Business Development, Coriolis Pharma
“This is the first news letter I read almost daily and I personally find it super useful.”
Greg Prikler
Director of Business Development, Mcule
“TLDR Biotech packs tons of useful information (good, bad, and ugly) into each daily newsletter. It's an easy, quick way to stay up to date on industry news, with links to more when you want to take a deep dive. I recommend it for staying on top of a rapidly changing industry as well as for business development fuel.”
Heather Johnson
Chief Content Officer, OutWord Bound Communications
“As a business developer in the drug discovery and preclinical field, staying updated is crucial. I highly recommend this biotech newsletter—it offers a well-curated selection of important developments, written in an engaging and fun way. It's the perfect way to break up my day while keeping me informed on the latest in the industry.”
Matthew Delport
Business Development Manager, Drug Discovery Services
“I go through cycles of newsletter subscriptions/cancellations. Right now I'm really appreciating TLDR Biotech:
Digestible summaries with links out to full reporting. Covered from a clinical development + M&A perspective More personality than the standard industry update Free”
Steve Wimmer
Vice President of Partnerships, 1nHealth
“A great newsletter for Business Development. Organized for Action!”
Jeanne Schow
SVP of Business Development at a Global CRO
“TLDR has become my go-to for easily accessible and organised BioPharma news. I love the way that all headlines are organised by category and is presented in an easy to read, informative and fun way.”
Philip Robinson
BioPharma and Healthtech Consultant at Philip Robinson Consulting
“I love the formatting, the GIFs are always spot on, and it's really easy to skim/read.”
Whitney Symons
Senior Customer Success Manager at Inventia Life Science
“TLDR Biotech is my one-stop-shop for biotech industry news. This daily newsletter presents the most important stories of the day it in a cleaver, easy to understand way.”
Anonymous
Analyst, Healthcare Investor Relations
Because maybe you're wondering, "Why is this the only biotech and pharma newsletter I'll actually need?"
Frequently Asked Questions